'Last Gen' Sequencing with Genia Technologies


Podcast Sponsor: DNAnexus- Unlocking the potential of DNA-based medicine and biotechnology with a collaborative and scalable DNA data management and analysis technology platform.

Guests:

Stefan Roever, CEO, Genia Technologies Bio and Contact Info

and later Roger Chen, CSO, Genia Technologies Bio and Contact Info

Listen (1:58) 'Last gen' sequencing!?

Listen (6:21) How does the technology work?

Listen (2:17) $100 chip, under $1000 reader

Listen (2:40) What level of analysis?

Listen (2:35) Technology not new, just the application

Listen (3:02) Current progress

Listen (2:51) Advantages over other systems

Listen (10:12) Are tech folks taking over bio?

Listen (2:38) On the verge of something big

Listen (10:02) Roger Chen theorizes about convergence of bio and IT

We’re coming to you from the 4th Personalized Medicine World Conference at the Computer History Museum in Mountain View, CA. Our guests are CEO, Stefan Roever, and CSO, Roger Chen of Genia Technologies. Genia is an emerging company with the aim of developing higher quality, less expensive sequencing for point-of-care.

Stefan is a serial entreprenuer and considered a visionary in the high tech industry. In 1994 he co-founded Brokat Technologies, and as CEO grew the company into a leading provider of Internet banking software with 1,400 employees in 17 countries. Named “Entrepreneur of the Year” in Germany in 1998 by Ernst & Young, Stefan was also ranked by Time magazine as number 11 on its Digital 25 A-List of “25 people who will change the way you work, phone and play.”

Roger Chen has over 10 years of analog/mixed signal electronics experience. He worked at Maxim Integrated Products, an industry leader in analog semiconductors. In 2001, Mr. Chen left Maxim and went back to school. He received his MS in Biochemistry from UC Santa Cruz. Mr. Chen also holds a BS in Electrical Engineering from MIT.



New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup